Skip to main content
Skip to primary sidebar
Skip to footer
240.243.1201
info@glycomimetics.com
Careers
Contact Us
About Us
Management Team
Board of Directors
Core Values
Patients
Clinical Trials
Expanded Access
Pipeline
Programs
Uproleselan/GMI-1687
GMI-1359
Galectin Antagonists
Rivipansel (GMI-1070)
Therapeutic Focus
Acute Myeloid Leukemia (AML)
Sickle Cell Disease
Technology & Publications
Scientific Publications
Intellectual Property
Platform & Research
Collaborations
Investors
Press Releases
Corporate Presentation
Events & Presentations
Corporate Governance
Management Team
Board of Directors
Committee Composition
Contact the Board
Financials & Filings
SEC Filings
Annual Reports and Proxies
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile
Careers
Contact Us
Search
Search
